EMBO Molecular Medicine (EMBO MM)

EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance. To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields: Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention). Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease. Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI) The journal is one of four EMBO Press journals run by in-house professional scientific editors. EMBO Molecular Medicine is supported by our academic Chief Editor, Prof. Philippe Sansonetti, and our broad and diverse advisory editorial board. Our journal is editorially independent of its publisher Springer Nature.

EMBO Molecular Medicine (EMBO MM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Molecular Medicine , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1757-4676, E-ISSN: 1757-4684, Established: 2009, Impact Factor: 7.795
• Does Not Provide Crossref DOI

• Indexed in: Scopus, DOAJ

• Not indexed in WoS, PubMed, UGC CARE